FENC
NASDAQ · Biotechnology
Fennec Pharmaceuticals Inc
$10.90
+0.26 (+2.44%)
Open$10.73
Previous Close$10.64
Day High$11.64
Day Low$10.26
52W High$13.25
52W Low$5.65
Volume—
Avg Volume144.6K
Market Cap345.24M
P/E Ratio—
EPS$-0.12
SectorBiotechnology
Analyst Ratings
Strong Buy
12 analysts
Price Target
+173.4% upside
Current
$10.90
$10.90
Target
$29.80
$29.80
$21.84
$29.80 avg
$37.23
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 56.53M | 74.30M | 77.18M |
| Net Income | -12,336,584 | -6,101,542 | -7,191,772 |
| Profit Margin | -21.8% | -8.2% | -9.3% |
| EBITDA | -10,516,314 | -9,610,170 | -10,191,915 |
| Free Cash Flow | — | -4,689,819 | -4,353,916 |
| Rev Growth | +207.2% | -7.2% | -5.1% |
| Debt/Equity | — | 0.51 | 0.45 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $294.45 | -0.18% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $467.06 | -0.22% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $167.95 | -1.05% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $542.62 | -0.81% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $951.19 | -0.86% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $156.65 | -2.00% | 7.7 | 20.98B |